Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Chemsyn Pharm CoBJSE:920656 61 5-Year Yield-on-Cost % is 2.65 as of Sep. 03, 2026, which is 25% above its 10-year median of 2.12. GuruFocus rates BJSE:920656 with a GF Score™ of 61/100 and a GF Value™ of ¥19.10 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 9 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks worse than 66.67% on this metric.
The historical rank and industry rank for Zhejiang Chemsyn Pharm Co's 5-Year Yield-on-Cost % or its related term are showing as below:
BJSE:920656'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.96 Med: 2.12 Max: 4.24
Current: 2.65
During the past 12 years, Zhejiang Chemsyn Pharm Co's highest Yield on Cost was 4.24. The lowest was 0.96. And the median was 2.12.
BJSE:920656's 5-Year Yield-on-Cost % is ranked worse than 66.67% of 9
companies
in the Healthcare Plans industry
Industry Median: 3.04
vs BJSE:920656: 2.65
Zhejiang Chemsyn Pharm Co (BJSE:920656) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Zhejiang Chemsyn Pharm Co 5-Year Yield-on-Cost % Related Terms
BJSE:920656 vs UNH, CVS, ELV: 5-Year Yield-on-Cost % Comparison
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co 5-Year Yield-on-Cost % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's 5-Year Yield-on-Cost % falls into.
Zhejiang Chemsyn Pharm Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a 5-Year Yield-on-Cost % of 2.65 as of Sep. 03, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. This is 25% above median its historical median of 2.12. Over the past decade, Zhejiang Chemsyn Pharm Co's 5-Year Yield-on-Cost % has ranged from 0.96 to 4.24. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #6 out of 9 companies in the Healthcare Plans industry, placing it in the top 66.7%.
Is Zhejiang Chemsyn Pharm Co's 5-Year Yield-on-Cost % too high?
Zhejiang Chemsyn Pharm Co's current 5-Year Yield-on-Cost % of 2.65 is 25% above median its 10-year median of 2.12. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 4.24. The Healthcare Plans industry median 5-Year Yield-on-Cost % is 3.04. Zhejiang Chemsyn Pharm Co's value of 2.65 is 12.8% below this industry median. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #6 out of 9 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's 5-Year Yield-on-Cost % compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #6 out of 9 companies for 5-Year Yield-on-Cost %. This places Zhejiang Chemsyn Pharm Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.04. Zhejiang Chemsyn Pharm Co's value of 2.65 is 12.8% below this benchmark. Historically, Zhejiang Chemsyn Pharm Co's own 5-Year Yield-on-Cost % has ranged from 0.96 to 4.24 over the past decade. While the company's 10-year median is 2.12 vs. the industry median of 3.04, Zhejiang Chemsyn Pharm Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Plans company?
The median 5-Year Yield-on-Cost % among Healthcare Plans companies is 3.04, based on 9 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Chemsyn Pharm Co's current 5-Year Yield-on-Cost % of 2.65 is 12.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median 5-Year Yield-on-Cost % is 3.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current 5-Year Yield-on-Cost % is 2.65, which is 25% above median its own 10-year median of 2.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Chemsyn Pharm Co (BJSE:920656) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.10, compared to a current price of ¥15.19 — trading 20.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 2.65, which is 25% above median its 10-year median of 2.12 and 12.8% below the Healthcare Plans industry median of 3.04. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current 5-Year Yield-on-Cost % is 2.65 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Chemsyn Pharm Co (BJSE:920656) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Chemsyn Pharm Co stock appears to be undervalued.
The current stock price of ¥15.19 is trading 20.5% below its estimated GF Value™ of ¥19.10.
GuruFocus considers Zhejiang Chemsyn Pharm Co to be Modestly Undervalued.
Key valuation signals for BJSE:920656:
5-Year Yield-on-Cost %: 2.65 (25% above median its 10-year median of 2.12)
GF Value™: ¥19.10 vs. price of ¥15.19 (20.5% below fair value)
Industry Position: 12.8% below the Healthcare Plans median (#6 of 9)
No single metric tells the full story. See the BJSE:920656 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
61GF Score
Get the complete analysis for BJSE:920656
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
